Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

Zaguán. Repositorio Digital de la Universidad de Zaragoza
Publicación Artículo científico (JournalArticle)

Inflammasome activation mediated by oxidised low-density lipoprotein in patients with sleep apnoea and early subclinical atherosclerosis

  • Díaz-García, E.
  • Sanz-Rubio, D.
  • García-Tovar, S.
  • Alfaro, E.
  • Cubero, P.
  • Gil, A. V.
  • Marín, J. M.
  • Cubillos-Zapata, C.
  • García-Río, F.
Atherosclerosis is a common comorbidity of obstructive sleep apnoea (OSA) patients, caused by the interaction of dyslipidaemia and systemic inflammation. The OSA pro-inflammatory response is mediated by NLRP3 inflammasome activation, which requires a priming signal mediated by intermittent hypoxia (IH) and an activation signal provided by soluble stimulus present in plasma. Our objectives were to study oxidised low-density lipoprotein (oxLDL) expression in OSA patients with or without early subclinical atherosclerosis (eSA) as well as its contribution to NLRP3 activation and tissue factor (TF) release.MethodsWe analysed oxLDL, key components of the NLRP3 inflammasome cascade and TF in plasma and monocytes from OSA patients and non-apnoeic subjects, with or without eSA as determined by increased carotid intima–media thickness without the appearance of atherosclerotic plaques. The oxLDL contribution to NLRP3 inflammasome activation was assessed usingin vitromodels.ResultsHigh levels of oxLDL were identified in plasma from OSA patients, particularly in those with eSA, as well as an overexpression of NLRP3 cascade components and TF. Furthermore,in vitromodels showed that both oxLDL and plasma from OSA patients with eSA act synergistically with IH as a priming and activation signal of NLRP3 that enhances the inflammatory response, pyroptosis and TF release.ConclusionsOSA patients with eSA exhibit NLRP3 activation by IH and the presence of oxLDL capable of releasing TF, constituting a pathway for the interaction between dyslipidaemia and systemic inflammation in the development of atherosclerotic lesions.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Obesity attenuates the effect of sleep apnea on active TGF-ß1 levels and tumor aggressiveness in patients with melanoma

  • Cubillos-Zapata, Carolina
  • Martínez García, Miguel Ángel|||0000-0002-7321-1891
  • Díaz-García, Elena
  • Jaureguizar, Ana
  • Campos-Rodríguez, Francisco
  • Sánchez de la Torre, Manuel|||0000-0002-5695-348X
  • Nagore, Eduardo|||0000-0003-3433-8707
  • Martorell-Calatayud, Antonio
  • Hernández Blasco, Luis Manuel
  • Pastor, Esther
  • Abad Capa, Jorge|||0000-0002-8129-7859
  • Montserrat, Josep María
  • Cabriada-Nuño, Valentín|||0000-0003-1124-7108
  • Cano Pumarega, Irene|||0000-0003-1543-7187
  • Corral-Peñafiel, Jaime
  • Arias, Eva
  • Mediano, Olga|||0000-0001-7824-1523
  • Somoza-González, María
  • Dalmau-Arias, Joan
  • Almendros, Isaac|||0000-0002-1998-9379
  • Farré, Ramon|||0000-0002-9084-7824
  • López-Collazo, Eduardo
  • Gozal, David|||0000-0001-8195-6036
  • García Rio, Francisco|||0000-0002-7227-2238
Active transforming growth factor-β1 (TGF-β1), a cytokine partially regulated by hypoxia and obesity, has been related with poor prognosis in several tumors. We determine whether obstructive sleep apnea (OSA) increases serum levels of active TGF-β1 in patients with cutaneous melanoma (CM), assess their relationship with melanoma aggressiveness and analyze the factors related to TGF-β1 levels in obese and non-obese OSA patients. In a multicenter observational study, 290 patients with CM were underwent sleep studies. TGF-β1 was increased in moderate-severe OSA patients vs. non-OSA or mild OSA patients with CM. In OSA patients, TGF-β1 levels correlated with mitotic index, Breslow index and melanoma growth rate, and were increased in presence of ulceration or higher Clark levels. In CM patients, OSA was associated with higher TGF-β1 levels and greater melanoma aggressiveness only in non-obese subjects. An in vitro model showed that IH-induced increases of TGF-β1 expression in melanoma cells is attenuated in the presence of high leptin levels. In conclusion, TGF-β1 levels are associated with melanoma aggressiveness in CM patients and increased in moderate-severe OSA. Moreover, in non-obese patients with OSA, TGF-β1 levels correlate with OSA severity and leptin levels, whereas only associate with leptin levels in obese OSA patients.